Concentra Group Holdings Parent Inc
CON19.630USD
+0.110+0.56%
Close 12/18, 16:00（ET）Quotes delayed by 15 min
2.52BMarket Cap
13.19P/E TTM
More Details of Concentra Group Holdings Parent Inc Company
Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.
Concentra Group Holdings Parent Inc Info
Ticker SymbolCON
Company nameConcentra Group Holdings Parent Inc
IPO dateJul 25, 2024
CEONewton (William Keith)
Number of employees8758
Security typeOrdinary Share
Fiscal year-endJul 25
Address5080 Spectrum Drive
CityADDISON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code75001
Phone19723648000
Website
Ticker SymbolCON
IPO dateJul 25, 2024
CEONewton (William Keith)
Company Executives of Concentra Group Holdings Parent Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-0.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
482.83K
+87.27%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+90.16%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+89.06%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+90.16%
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Dr. Marc R. Watkins, M.D.
Dr. Marc R. Watkins, M.D.
Independent Director
Independent Director
--
--
Ms. Su Zan Nelson, CPA
Ms. Su Zan Nelson, CPA
Executive Vice President, Chief Accounting Officer
Executive Vice President, Chief Accounting Officer
--
--
Mr. Douglas R. Mcandrew
Mr. Douglas R. Mcandrew
Executive Vice President, Chief Operating Officer - West
Executive Vice President, Chief Operating Officer - West
--
--
Mr. Michael A. Kosuth
Mr. Michael A. Kosuth
Executive Vice President, Chief Operating Officer - East
Executive Vice President, Chief Operating Officer - East
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-0.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
482.83K
+87.27%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+90.16%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+89.06%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+90.16%
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
By BusinessUSD
Name
Revenue
Proportion
Occupational health centers - Workers compensation
332.19M
60.31%
Occupational health centers - Employer services
174.32M
31.65%
Onsite clinics
22.57M
4.10%
Other
12.08M
2.19%
Occupational health centers - Consumer health
7.18M
1.30%
Other occupational health center revenue
2.45M
0.45%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Occupational health centers - Workers compensation
332.19M
60.31%
Occupational health centers - Employer services
174.32M
31.65%
Onsite clinics
22.57M
4.10%
Other
12.08M
2.19%
Occupational health centers - Consumer health
7.18M
1.30%
Other occupational health center revenue
2.45M
0.45%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
10.28%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Other
52.81%
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
10.28%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Other
52.81%
Shareholder Types
Shareholders
Proportion
Investment Advisor
59.75%
Investment Advisor/Hedge Fund
18.12%
Individual Investor
10.71%
Hedge Fund
6.66%
Research Firm
2.49%
Sovereign Wealth Fund
1.21%
Pension Fund
1.17%
Bank and Trust
0.75%
Insurance Company
0.03%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
468
115.54M
92.17%
+1.31K
2025Q3
468
115.54M
92.15%
+6.14M
2025Q2
437
109.05M
87.68%
-456.06K
2025Q1
406
109.58M
85.04%
+578.97K
2024Q4
355
109.93M
36.49%
+63.12M
2024Q3
113
28.34M
4.83%
+22.18M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Associates, Inc.
13.76M
10.74%
-827.64K
-5.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.27M
11.92%
-10.34K
-0.07%
Jun 30, 2025
The Vanguard Group, Inc.
13.15M
10.26%
+1.05M
+8.65%
Jun 30, 2025
Ortenzio (Robert A)
8.25M
6.43%
+1.01M
+13.96%
Mar 03, 2025
T. Rowe Price Investment Management, Inc.
7.66M
5.98%
+108.33K
+1.43%
Jun 30, 2025
State Street Investment Management (US)
4.27M
3.33%
+52.88K
+1.25%
Jun 30, 2025
Rocco A. Ortenzio UEO
3.30M
2.57%
-3.07M
-48.22%
Mar 03, 2025
Thrivent Asset Management, LLC
2.30M
1.79%
-210.45K
-8.38%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
3.20M
2.5%
-54.90K
-1.69%
Jun 30, 2025
JP Morgan Asset Management
2.67M
2.08%
+135.19K
+5.33%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Texas Capital Texas Small Cap Equity Index ETF
2.5%
State Street SPDR S&P Health Care Services ETF
1.88%
Invesco S&P SmallCap Health Care ETF
1.45%
Harbor Human Capital Factor US Small Cap ETF
0.8%
JPMorgan Active Small Cap Value ETF
0.79%
Texas Capital Texas Equity Index ETF
0.62%
Invesco S&P SmallCap Quality ETF
0.54%
JPMorgan Fundamental Data Science Small Core ETF
0.51%
T Rowe Price Small-Mid Cap ETF
0.45%
iShares U.S. Healthcare Providers ETF
0.37%
View more
Texas Capital Texas Small Cap Equity Index ETF
Proportion2.5%
State Street SPDR S&P Health Care Services ETF
Proportion1.88%
Invesco S&P SmallCap Health Care ETF
Proportion1.45%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.8%
JPMorgan Active Small Cap Value ETF
Proportion0.79%
Texas Capital Texas Equity Index ETF
Proportion0.62%
Invesco S&P SmallCap Quality ETF
Proportion0.54%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.51%
T Rowe Price Small-Mid Cap ETF
Proportion0.45%
iShares U.S. Healthcare Providers ETF
Proportion0.37%
Dividend
A total of
7.96M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 06, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Dec 09, 2025 going ex on Dec 02, 2025
Dec 02, 2025
Dec 09, 2025
Dec 02, 2025
Aug 07, 2025
CON.NB Final Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 21, 2025
Aug 21, 2025
Aug 28, 2025
Aug 21, 2025
May 07, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 20, 2025
May 20, 2025
May 29, 2025
May 20, 2025
Feb 28, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Apr 01, 2025 going ex on Mar 18, 2025
Mar 18, 2025
Apr 01, 2025
Mar 18, 2025
Oct 31, 2024
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Nov 22, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 22, 2024
Nov 13, 2024
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Concentra Group Holdings Parent Inc?
The top five shareholders of Concentra Group Holdings Parent Inc are:
T. Rowe Price Associates, Inc. holds 13.76M shares, accounting for 10.74% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 15.27M shares, accounting for 11.92% of the total shares.
The Vanguard Group, Inc. holds 13.15M shares, accounting for 10.26% of the total shares.
Ortenzio (Robert A) holds 8.25M shares, accounting for 6.43% of the total shares.
T. Rowe Price Investment Management, Inc. holds 7.66M shares, accounting for 5.98% of the total shares.
T. Rowe Price Associates, Inc. holds 13.76M shares, accounting for 10.74% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 15.27M shares, accounting for 11.92% of the total shares.
The Vanguard Group, Inc. holds 13.15M shares, accounting for 10.26% of the total shares.
Ortenzio (Robert A) holds 8.25M shares, accounting for 6.43% of the total shares.
T. Rowe Price Investment Management, Inc. holds 7.66M shares, accounting for 5.98% of the total shares.
What are the top three shareholder types of Concentra Group Holdings Parent Inc?
The top three shareholder types of Concentra Group Holdings Parent Inc are:
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of Concentra Group Holdings Parent Inc (CON)?
As of 2025Q4, 468 institutions hold shares of Concentra Group Holdings Parent Inc, with a combined market value of approximately 115.54M, accounting for 92.17% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.02%.
What is the biggest source of revenue for Concentra Group Holdings Parent Inc?
In FY2025Q2, the Occupational health centers - Workers compensation business generated the highest revenue for Concentra Group Holdings Parent Inc, amounting to 332.19M and accounting for 60.31% of total revenue.
